Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum in: Lancet Diabetes Endocrinol. 2019 Jul 8;:. Lancet Diabetes Endocrinol. 2019 Sep;7(9):e21.

PMID:
31272931
2.

Short- and long-term results with a percutaneous treatment in critical hand ischaemia.

Ruzsa Z, Berta B, Tóth J, Nemes B, Katona A, Hüttl A, Ungi I, Bertrand OF, Merkely B.

Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1301-1310. doi: 10.1002/ccd.28166. Epub 2019 Mar 29.

PMID:
30927324
3.

Screening of mecI Gene in Staphylococcus Strains Isolated in Transylvania Region of Romania.

Jakab E, Colcieru M, Jakab RI, Gabri EE, Lázár CH, Török E, Kremmer B, Mészáros TJ, Katona Á, Fazakas E, Coldea L, Popescu O.

Microb Drug Resist. 2019 Jun;25(5):639-643. doi: 10.1089/mdr.2018.0205. Epub 2019 Jan 3.

PMID:
30614756
4.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574
5.

[Lipid-lowering therapy of patients suffering from acute coronary syndrome in a Hungarian county hospital in 2015].

Márk L, Nagy M, Dani G, Baranyai C, Borbély M, Katona A, Jambrik Z.

Orv Hetil. 2018 Mar;159(12):478-484. doi: 10.1556/650.2018.31022. Hungarian.

PMID:
29552926
6.

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group.

N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

7.

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.

Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P; EINSTEIN CHOICE Investigators.

N Engl J Med. 2017 Mar 30;376(13):1211-1222. doi: 10.1056/NEJMoa1700518. Epub 2017 Mar 18.

8.

[Hungarian Heart Failure Registry 2015-2016. Preliminary results].

Nyolczas N, Heltai K, Borbély A, Habon T, Járai Z, Sziliczei E, Stadler P, Faludi R, Herczeg B, Papp E, Lakatos F, Nagy K, Katona A, Kovács I, Tomcsányi J, Nagy A, Sepp R.

Orv Hetil. 2017 Jan;158(3):94-100. doi: 10.1556/650.2017.30671. Hungarian.

PMID:
28110567
9.

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.

Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR; EUCLID Trial Steering Committee and Investigators.

N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13.

10.

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.

Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM; APEX Investigators.

N Engl J Med. 2016 Aug 11;375(6):534-44. doi: 10.1056/NEJMoa1601747. Epub 2016 May 27.

11.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

12.

Do I Buy It? How AIDET™ Training Changes Residents' Values about Patient Care.

Braverman AM, Kunkel EJ, Katz L, Katona A, Heavens T, Miller A, Arfaa JJ.

J Patient Exp. 2015 May;2(1):13-20. doi: 10.1177/237437431500200104. Epub 2015 May 1.

13.

Left circumflex coronary artery occlusion due to a left atrial appendage closure device.

Katona A, Temesvári A, Szatmári A, Nemes A, Forster T, Fontos G.

Postepy Kardiol Interwencyjnej. 2015;11(1):69-70. doi: 10.5114/pwki.2015.49192. Epub 2015 Mar 6.

14.

Improvement in prehospital time in acute coronary syndrome between 1985 and 2013 in the south-eastern area of Hungary.

Mark L, Dani G, Vendrey R, Ruzsa J, Katona A.

Wien Klin Wochenschr. 2015 Mar;127(5-6):218-21. doi: 10.1007/s00508-015-0717-7. Epub 2015 Mar 21.

PMID:
25794562
15.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators.

N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.

16.

Oral anticoagulant therapy and bleeding events with vitamin K antagonists in patients with atrial fibrillation in a Hungarian county hospital.

Mark L, Dani G, Vendrey R, Paragh G, Katona A.

Med Sci Monit. 2015 Feb 17;21:518-25. doi: 10.12659/MSM.892360.

17.

Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.

Smith KM, Eyal E, Weintraub D; ADAGIO Investigators.

JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472.

PMID:
25420207
18.

Interaction between digoxin and dronedarone in the PALLAS trial.

Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ; PALLAS investigators.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.

PMID:
25378467
19.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

O'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators, Steen DL.

JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061. Erratum in: JAMA. 2014 Oct 8;312(14):1473. Dylan P. Steen[corrected to Dylan L. Steen].

PMID:
25173516
20.

[Short and long term prognosis of patients with myocardial infarction. Hungarian Myocardial Infarction Registry].

Jánosi A, Ofner P, Merkely B, Polgár P, Zámolyi K, Kiss RG, Edes I, Csapó K, Nagy L, Lupkovics G, Herceg B, Tomcsányi J, László Z, Vértes A, Simon J, Katona A, Juhász F, Bajkó F, Varjú I, Dinya E.

Orv Hetil. 2013 Aug 18;154(33):1297-302. doi: 10.1556/OH.2013.29679. Hungarian.

PMID:
23933608

Supplemental Content

Loading ...
Support Center